What factors affect Aerius dosage?
Aerius® is primarily used as a long -acting treatment of symptoms of seasonal and chronic allergies, as well as for the treatment of itching and chronic idiopathic urticaria and to reduce the occurrence and severity of hives. Compared to the antihistamines of the first generation Aerius® and other second generation antihistamines, they do not create drowsiness as often or intense, as they do not easily exceed the blood -brain barrier at low doses. Since drugs can produce considerable drowsiness at high doses, it is important to consider factors such as the patient's age and the level of liver or kidney function, which may affect its appropriate Aerius® dosage levels.
When a patient suffering from allergic rhinitis first takes a medicine, the recommended initial dose of Aerius® in adults is 5 mg administered orally once a day. If one dose of 5 mg does not provide sufficient relationyief symptoms within 70 minutes after ingestion may be givenA single dose of maintenance 5 mg. Since drugs remain active for 24 hours, the total Aerius® dose greater than 10 mg per day is likely to cause drowsiness and interfere with operating motor vehicles or heavy machines. Since 2011, the safety and effectiveness of the drug has not been convincingly studied in children under the age of 12, so that the manufacturer does not offer any official dosing recommendations for these patients. Existing research suggests that children aged six and 12 months receive Aerius® dosage 1 mg orally once a day, they receive 0.25 mg more between one and six years, and they receive 2.5 mg aged six and 11 years.
Research on the treatment of chronic idiopathic urticaria in pediatric patients suggests the use of the same Aerius® dosing instructions as for the treatment of allergic rhinitis in children. Aerius® adults for the same condition should receive 5 mg once a day and, if necessary, a maintenance dose of 5 mg. When the patient reduces the level of liver function nEbo kidneys, maintenance doses should only be administered every other day. Although no studies on the effects of peritoneal dialysis on Aerius® levels have not been carried out since 2011, it is known that the drug is not removed by hemodialysis and that dose adjustments are not required.
Aerius® is a trade name for drug demoratadin. General drugs are also sold under NeoClarityn®, Claramax®, Clarinex®, Larinex®, Dub® and Delot®. A member of the drug class known as second -generation antihistamines, Aerius® is somewhat chemically similar to tricyclic antidepressants and is very closely related to allergic drugs Loratadin.